NEUROSENSE THERAPEUTICS LTD (NRSN)

IL0011809592 - Common Stock

1.82  +0.09 (+5.2%)

After market: 1.82 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
13.40M13.55M5.59M2.89M1.24M
Research and Development
7.17M6.42M3.08M2.50M900.00K
Selling, General, and Administrative Expenses
6.22M7.14M2.51M390.00K340.00K
Operating Income
-13.40M-13.55M-5.59M-2.89M-1.24M
Interest Income/Expense
1.91M1.21M1.89M60.00K10.00K
Other Income/Expense
N/AN/A-340.00KN/AN/A
Income Before Taxes
-11.49M-12.34M-4.04M-2.83M-1.22M
Net Income
-11.49M-12.34M-4.04M-2.83M-1.22M
EBITDA
N/A-13.46MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.86-1.07-0.37-0.25-0.11
 
Statistics

All data in USD

Charts